Maman, A. 2023. Lutetium-177 Prostate-Specific Membrane Antigen-617 Treatment in Metastatic Castration-Resistant Prostate Adenocarcinoma: Results of Single-Center Experience. EURASIAN JOURNAL OF MEDICINE , vol.55, no.2 , 109-113.

Maman, A., (2023). Lutetium-177 Prostate-Specific Membrane Antigen-617 Treatment in Metastatic Castration-Resistant Prostate Adenocarcinoma: Results of Single-Center Experience. EURASIAN JOURNAL OF MEDICINE , vol.55, no.2, 109-113.

Maman, Adem. "Lutetium-177 Prostate-Specific Membrane Antigen-617 Treatment in Metastatic Castration-Resistant Prostate Adenocarcinoma: Results of Single-Center Experience," EURASIAN JOURNAL OF MEDICINE , vol.55, no.2, 109-113, 2023

Maman, Adem. "Lutetium-177 Prostate-Specific Membrane Antigen-617 Treatment in Metastatic Castration-Resistant Prostate Adenocarcinoma: Results of Single-Center Experience." EURASIAN JOURNAL OF MEDICINE , vol.55, no.2, pp.109-113, 2023

Maman, A. (2023) . "Lutetium-177 Prostate-Specific Membrane Antigen-617 Treatment in Metastatic Castration-Resistant Prostate Adenocarcinoma: Results of Single-Center Experience." EURASIAN JOURNAL OF MEDICINE , vol.55, no.2, pp.109-113.

@article{article, author={Adem MAMAN}, title={Lutetium-177 Prostate-Specific Membrane Antigen-617 Treatment in Metastatic Castration-Resistant Prostate Adenocarcinoma: Results of Single-Center Experience}, journal={EURASIAN JOURNAL OF MEDICINE}, year=2023, pages={109-113} }